AI Article Synopsis

Article Abstract

Staphylococcus epidermidis is the main cause of bacteremia and infections of indwelling catheters, glycopeptide antibiotics are often considered as the choice of empirical drugs for the treatment of staphylococcal infections. In the present study, 12 teicoplanin nonsusceptible S. epidermidis isolates were collected between January and October 2013. All strains carried the mecA gene, displayed multiple drug resistance, and showed heterogeneous resistance to vancomycin using the population analysis profiling/area under the curve method. Multilocus sequence typing revealed four different sequence types among these isolates; eight isolates belonged to the same ST type (ST267). Pulsed-field gel electrophoresis (PFGE) with SmaI endonuclease showed four distinct pulsotypes. Six isolates that belonged to ST267 shared the same PFGE bands, indicating that they were clonally related. In addition, cell wall thickening and decreased autolysis were found in these isolates. Our study demonstrated that ST267 was the most epidemic clone among teicoplanin nonsusceptible S. epidermidis and identified a potential endemic clone in this region, which was believed to be the first report that the ST267 clone has spread in China. Our findings revealed that strengthened monitoring of S. epidermidis for drug resistance to glycopeptide antibiotics is urgently needed, and heightened measures should be taken to control the further spread of the ST267 clone.

Download full-text PDF

Source
http://dx.doi.org/10.1089/mdr.2015.0321DOI Listing

Publication Analysis

Top Keywords

teicoplanin nonsusceptible
12
staphylococcus epidermidis
8
glycopeptide antibiotics
8
nonsusceptible epidermidis
8
drug resistance
8
isolates belonged
8
st267 clone
8
isolates
6
st267
6
epidermidis
5

Similar Publications

Article Synopsis
  • The study investigates the rise of vancomycin-resistant Staphylococcus aureus (VRSA) since 2010, finding that 2.4% of S. aureus infections are now VRSA, along with challenges posed by hVISA isolates.
  • Researchers analyzed 845 isolates, confirming 246 as S. aureus, with molecular techniques identifying various vancomycin resistance genes, especially vanA, vanB, and vanD.
  • Results indicated that a notable percentage (8%) of isolates exhibited glycopeptide non-susceptibility, with some showing a concerning increase in minimum inhibitory concentration (MIC), which could complicate infection control efforts and antibiotic guidelines.
View Article and Find Full Text PDF

Genetic and Phenotypic Changes Related to the Development of -Independent Oxacillin Non-Susceptibility in ST8 Recovered after Antibiotic Therapy in a Patient with Bacteremia.

Antibiotics (Basel)

June 2024

Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autómoma de Buenos Aires 1113, Argentina.

The -independent oxacillin non-susceptible (MIONSA) strains represent a great clinical challenge, as they are not easily detected and can lead to treatment failure. However, the responsible molecular mechanisms are still very little understood. Here, we studied four clinical ST8-MSSA- isolates recovered during the course of antibiotic treatment from a patient suffering successive episodes of bacteremia.

View Article and Find Full Text PDF

Serotype distribution and antimicrobial resistance of among children with acute otitis media in Marrakech, Morocco.

Iran J Microbiol

February 2022

Department of Medical Biology, Laboratory of Microbiology and Virology, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakesh, Morocco.

Background And Objectives: is one of the most frequent pathogens leading to a variety of clinical manifestations. The effects of carriage on acute otitis media (AOM) are poorly studied. The study aimed to assess the serotype's distribution and antimicrobial susceptibility in children with AOM after the implementation of the pneumococcal conjugate vaccine (PCV) in Morocco.

View Article and Find Full Text PDF

A patient with end-stage renal disease received 2 doses of dalbavancin for methicillin-resistant Staphylococcus aureus (MRSA) arteriovenous fistula infection and presented 5 weeks later with infective endocarditis secondary to vancomycin, daptomycin, and dalbavancin nonsusceptible MRSA. Resistance was associated with walK and scrA mutations, reduced long-chain lipid content, and reduced membrane fluidity.

View Article and Find Full Text PDF

Dalbavancin was approved in Europe in 2015 for skin and soft tissue infections. Data on methicillin-resistant coagulase-negative staphylococci (MR-CNS) dalbavancin susceptibility are scarce. To assess the susceptibility of MR-CNS to dalbavancin and other anti-staphylococcal agents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!